Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter W de Herder

Showing results (31-40 of 238) with videos related to

Pageof 24
Sort By:
Journal of Neuroendocrinology|November 20, 2024
Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumoursJelka Kuiper, Eline Zoetelief, Tessa Brabander, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2016
A short history of neuroendocrine tumours and their peptide hormonesWouter W de Herder, Jens F Rehfeld, Mark Kidd, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 22, 2019
From dwarves to giants: South American's contribution to the history of growth hormone and related disordersCesar Luiz Boguszewski, Margaret Cristina da Silva Boguszewski, Wouter W de Herder
Endocrine-Related Cancer|January 5, 2019
Management of carcinoid syndrome: a systematic review and meta-analysisJohannes Hofland, Aura D Herrera-Martínez, Wouter T Zandee, et al.
Endocrine-Related Cancer|December 24, 2011
Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreasKimberly Kamp, Ronald A M Damhuis, Richard A Feelders, et al.
Expert Opinion on Therapeutic Targets|September 3, 2013
Targeting the somatostatin receptor in pituitary and neuroendocrine tumorsMarije J Veenstra, Wouter W de Herder, Richard A Feelders, et al.
Endocrine-Related Cancer|December 14, 2017
Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrumAnela Blažević, Johannes Hofland, Leo J Hofland, et al.
Drugs|June 6, 2013
Recent developments in drug therapy for Cushing's diseaseRob van der Pas, Wouter W de Herder, Leo J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2022
Peptide Receptor Radionuclide TherapyJohannes Hofland, Tessa Brabander, Frederik A Verburg, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2023
Approach to the Patient: InsulinomaJohannes Hofland, Julie C Refardt, Richard A Feelders, et al.
Pageof 24

Showing results (31-40 of 238) with videos related to

Sort By:
Pageof 24
Journal of Neuroendocrinology|November 20, 2024
Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumoursJelka Kuiper, Eline Zoetelief, Tessa Brabander, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2016
A short history of neuroendocrine tumours and their peptide hormonesWouter W de Herder, Jens F Rehfeld, Mark Kidd, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 22, 2019
From dwarves to giants: South American's contribution to the history of growth hormone and related disordersCesar Luiz Boguszewski, Margaret Cristina da Silva Boguszewski, Wouter W de Herder
Endocrine-Related Cancer|January 5, 2019
Management of carcinoid syndrome: a systematic review and meta-analysisJohannes Hofland, Aura D Herrera-Martínez, Wouter T Zandee, et al.
Endocrine-Related Cancer|December 24, 2011
Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreasKimberly Kamp, Ronald A M Damhuis, Richard A Feelders, et al.
Expert Opinion on Therapeutic Targets|September 3, 2013
Targeting the somatostatin receptor in pituitary and neuroendocrine tumorsMarije J Veenstra, Wouter W de Herder, Richard A Feelders, et al.
Endocrine-Related Cancer|December 14, 2017
Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrumAnela Blažević, Johannes Hofland, Leo J Hofland, et al.
Drugs|June 6, 2013
Recent developments in drug therapy for Cushing's diseaseRob van der Pas, Wouter W de Herder, Leo J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2022
Peptide Receptor Radionuclide TherapyJohannes Hofland, Tessa Brabander, Frederik A Verburg, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2023
Approach to the Patient: InsulinomaJohannes Hofland, Julie C Refardt, Richard A Feelders, et al.
Pageof 24